Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Operating Expenses | 3,371 | 2,664 | 4,568 | 1,561 | 1,640 |
| Operating Income | -3,371 | -2,664 | -4,568 | -1,561 | -1,640 |
| Interest Expense | 83 | 646 | 745 | 679 | 1,241 |
| Other Income | -27,429 | -2,223 | -858 | 211 | -652 |
| Pre-tax Income | -30,883 | -5,533 | -6,172 | -2,029 | -3,533 |
| Net Income Continuous | -30,883 | -5,533 | -6,172 | -2,029 | -3,533 |
| Net Income | $-30,883 | $-5,533 | $-6,172 | $-2,029 | $-3,533 |
| EPS Basic Total Ops | -240.10 | -584.63 | -1,130.85 | -480.19 | -1,080.43 |
| EPS Basic Continuous Ops | -239.73 | -584.66 | -1,131.18 | -529.56 | -1,065.46 |
| EPS Diluted Total Ops | -240.10 | -584.63 | -1,130.85 | -480.19 | -1,080.43 |
| EPS Diluted Continuous Ops | -239.73 | -584.66 | -1,131.18 | -529.56 | -1,065.46 |
| EBITDA(a) | $-3,371 | $-2,664 | $-4,568 | $-1,561 | $-1,640 |